Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hannah Yellin, Curt Beckwith, Ann Kurth, Tao Liu, Breana Castonguay, Rudy Patrick, Claudia Trezza, Lauri Bazerman & Irene Kuo. (2018) Syndemic effect of mental illness and substance use on viral suppression among recently-incarcerated, HIV-infected individuals in the CARE+ Corrections study. AIDS Care 30:10, pages 1252-1256.
Read now
Read now
Miguel Angel Gonzalez-Torres, Miguel Angel Salazar, Manuel Imaz, Lucía Inchausti, Berta Ibañez, Aranzazu Fernandez-Rivas, Javier Pastor, Bosco Anguiano, Pedro Muñoz, Eduardo Ruiz, Rodrigo Oraa, Sonia Bustamante, Sofia Alvarez de Eulate & Ramón Cisterna. (2015) Undertreatment of human immunodeficiency virus in psychiatric inpatients: a cross-sectional study of seroprevalence and associated factors. Neuropsychiatric Disease and Treatment 11, pages 1421-1426.
Read now
Read now
Enrico G. Ferro, Damian Weikum, Panagiotis Vagenas, Michael M. Copenhaver, Pedro Gonzales, Jesus Peinado, Robinson Cabello, Javier R. Lama, Jorge Sanchez & Frederick L. Altice. (2015) Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru. AIDS Care 27:1, pages 93-104.
Read now
Read now
Jo Brocato, DennisG. Fisher, GraceL. Reynolds & MikeA. Janson. (2014) Drug Treatment Utilization Among Illicit Drug Users Receiving HIV Prevention Services in Los Angeles County. Journal of HIV/AIDS & Social Services 13:2, pages 125-143.
Read now
Read now
Santosh Kumar, Mengyao Jin, Anusha Ande, Namita Sinha, Peter S Silverstein & Anil Kumar. (2012) Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes. Expert Opinion on Drug Metabolism & Toxicology 8:11, pages 1363-1375.
Read now
Read now
Ifeoma Ezeabogu, MichaelM. Copenhaver & Jessica Potrepka. (2012) The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS. AIDS Care 24:3, pages 386-393.
Read now
Read now
Articles from other publishers (44)
Sorochi Iloanusi, Ismaeel Yunusa, Osaro Mgbere, Susan M. Abughosh, Hua Chen & Ekere J. Essien. (2023) Development and internal validation of a risk prediction model for HIV disease severity among people living with HIV and mental illness or substance use disorder. Annals of Epidemiology 87, pages 79-92.
Crossref
Crossref
Hudson ReddonNadia FairbairnCameron Grant & M-J Milloy. (2023) Experiencing homelessness and progression through the HIV cascade of care among people who use drugs. AIDS 37:9, pages 1431-1440.
Crossref
Crossref
Alice K. Min, Trinisia Fortune, Natalia Rodriguez, Esha Hedge & Talia H. Swartz. (2023) Inflammasomes as mediators of inflammation in HIV-1 infection. Translational Research 252, pages 1-8.
Crossref
Crossref
Hudson Reddon, M. Eugenia Socias, Amy Justice, Zishan Cui, Ekaterina Nosova, Rolando Barrios, Nadia Fairbairn, Brandon D. L. Marshall & M.-J. Milloy. (2022) Periods of Homelessness Linked to Higher VACS Index Among HIV-Positive People Who Use Drugs. AIDS and Behavior 26:6, pages 1739-1749.
Crossref
Crossref
Ni Gusti Ayu Nanditha, Xinzhe Dong, Hiwot M. Tafessu, Lu Wang, Michelle Lu, Rolando Barrios, Julio S.G. Montaner & Viviane D. Lima. (2022) A province-wide HIV initiative to accelerate initiation of treatment-as-prevention and virologic suppression in British Columbia, Canada: a population-based cohort study. CMAJ Open 10:1, pages E27-E34.
Crossref
Crossref
Catherine R. Lesko, Heidi E. Hutton, Anthony T. Fojo, Nicola M. Shen, Richard D. Moore & Geetanjali Chander. (2021) Depression and HIV viral nonsuppression among people engaged in HIV care in an urban clinic, 2014–2019. AIDS 35:12, pages 2017-2024.
Crossref
Crossref
Rupali Kotwal Doshi, Morgan Byrne, Matthew Levy, Leah Varga, Irene Kuo, Michael A. Horberg, Amanda D. Castel & Anne K. Monroe. (2021) Association of Substance Use Disorders with Engagement in Care and Mortality among a Clinical Cohort of People with HIV in Washington, DC. AIDS and Behavior 25:7, pages 2289-2300.
Crossref
Crossref
Amanda Blair SpenceKatherine MichelCuiwei WangMary Ann DuttonKathryn LeeDaniel MerensteinLucile Adams-CampbellKatheryn BellAnjali KikkisettiAllison DoyleMikayla CochraneLakshmi GoparajuSeble Kassaye. (2021) Viral Suppression Is Associated with HIV Treatment Self-Efficacy in a Cohort of Women in Washington, DC. AIDS Patient Care and STDs 35:3, pages 75-83.
Crossref
Crossref
Kathy K. Byrd, Felicia Hardnett, John G. Hou, Patrick G. Clay, Sumihiro Suzuki, Nasima M. Camp, Michael D. Shankle, Paul J. Weidle & Michael S. Taitel. (2020) Improvements in Retention in Care and HIV Viral Suppression Among Persons with HIV and Comorbid Mental Health Conditions: Patient-Centered HIV Care Model. AIDS and Behavior 24:12, pages 3522-3532.
Crossref
Crossref
Kathleen A McManus, Joshua Ferey, Elizabeth Farrell & Rebecca Dillingham. (2020) National Survey of US HIV Clinicians: Knowledge and Attitudes About the Affordable Care Act and Opinions of its Impact on Quality of Care and Barriers to Care. Open Forum Infectious Diseases 7:7.
Crossref
Crossref
Jingjing Meng, Santanu Banerjee, Li Zhang, Greg Sindberg, Shamsudheen Moidunny, Bin Li, David J. Robbins, Mohit Girotra, Bradley Segura, Sundaram Ramakrishnan & Sabita Roy. (2020) Opioids Impair Intestinal Epithelial Repair in HIV-Infected Humanized Mice. Frontiers in Immunology 10.
Crossref
Crossref
Russell Brewer, Rodal Issema, Mary Moore, Sarah Chrestman, Snigdha Mukherjee, Michelle Odlum & John A. Schneider. (2019) Correlates of Durable Viral Suppression (DVS) Among Criminal Justice-involved (CJI) Black Men Living with HIV in Louisiana. AIDS and Behavior 23:11, pages 2980-2991.
Crossref
Crossref
Srijita Mondal, Priyanka Ghosh, Dibyendu Biswas & Priti Kumar Roy. (2019) Effect of Alcohol Consumption during Antiretroviral Therapy on HIV-1 Replication: Role of Cytochrome P3A4 Enzyme. International Journal of Mathematical, Engineering and Management Sciences 4:4, pages 922-935.
Crossref
Crossref
Raina Aggarwal, Michael Pham, Rebecca Dillingham & Kathleen A McManus. (2019) Expanded HIV Clinic–Based Mental Health Care Services: Association With Viral Suppression. Open Forum Infectious Diseases 6:4.
Crossref
Crossref
Anthony T. Fojo, Catherine R. Lesko, Keri L. Calkins, Richard D. Moore, Mary E. McCaul, Heidi E. Hutton, William C. Mathews, Heidi Crane, Katerina Christopoulos, Karen Cropsey, Michael J. Mugavero, Kenneth Mayer, Brian W. Pence, Bryan Lau & Geetanjali Chander. (2018) Do Symptoms of Depression Interact with Substance Use to Affect HIV Continuum of Care Outcomes?. AIDS and Behavior 23:3, pages 580-591.
Crossref
Crossref
Néstor Szerman, Carlos Parro-Torres, Javier Didia-Attas & Nady El-Guebaly. 2019. Advances in Psychiatry. Advances in Psychiatry
109
127
.
Mary Clare Kennedy, Thomas H. Kerr, Evan Wood, Jeannie A. Shoveller, Julio S.G. Montaner & M-J S. Milloy. (2018) Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users. AIDS 32:8, pages 1059-1067.
Crossref
Crossref
Linda Chang & Dinesh K. Shukla. 2018. The Neurology of HIV Infection. The Neurology of HIV Infection
229
264
.
Ellen W. Wiewel, Luisa N. Borrell, Heidi E. Jones, Andrew R. Maroko & Lucia V. Torian. (2017) Neighborhood Characteristics Associated with Achievement and Maintenance of HIV Viral Suppression Among Persons Newly Diagnosed with HIV in New York City. AIDS and Behavior 21:12, pages 3557-3566.
Crossref
Crossref
Sitaji Gurung, Ana Ventuneac, Demetria Cain, Chloe Mirzayi, Christopher Ferraris, H. Jonathon Rendina, Martha A. Sparks & Jeffrey T. Parsons. (2017) Alcohol and substance use diagnoses among HIV-positive patients receiving care in NYC clinic settings. Drug and Alcohol Dependence 180, pages 62-67.
Crossref
Crossref
Christinah Mukandavire, Andrea Low, Gitau Mburu, Adam Trickey, Margaret T. May, Charlotte F. Davies, Clare E. French, Katharine J. Looker, Tim Rhodes, Lucy Platt, Andy Guise, Matthew Hickman & Peter Vickerman. (2017) Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs. AIDS 31:8, pages 1181-1190.
Crossref
Crossref
Mary Clare Kennedy, Thomas Kerr, Ryan McNeil, Surita Parashar, Julio Montaner, Evan Wood & M.-J. Milloy. (2016) Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs. AIDS and Behavior 21:3, pages 678-687.
Crossref
Crossref
Daniel J. Feller & Bruce D. Agins. (2016) Understanding Determinants of Racial and Ethnic Disparities in Viral Load Suppression. Journal of the International Association of Providers of AIDS Care (JIAPAC) 16:1, pages 23-29.
Crossref
Crossref
Rui Fu, Alexander Gutfraind & Margaret L. Brandeau. (2016) Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections. Mathematical Biosciences 273, pages 102-113.
Crossref
Crossref
Sandra Schwarcz, Ling Chin Hsu & Susan Scheer. (2015) Disparities and Trends in Viral Suppression During a Transition to a “Test and Treat” Approach to the HIV Epidemic, San Francisco, 2008–2012. JAIDS Journal of Acquired Immune Deficiency Syndromes 70:5, pages 529-537.
Crossref
Crossref
Alan S. Karstaedt, Sadhna Kooverjee, Lucille Singh, Yasmien Jeenah & Gregory Jonsson. (2015) Antiretroviral Therapy Outcomes in Patients with Severe Mental Illness. Journal of the International Association of Providers of AIDS Care (JIAPAC) 14:5, pages 428-433.
Crossref
Crossref
Jessica F. Magidson, Alyson Listhaus, C. J. Seitz-Brown, Steven A. Safren, C. W. Lejuez & Stacey B. Daughters. (2014) Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users?. Journal of Behavioral Medicine 38:2, pages 337-347.
Crossref
Crossref
Sean J. HaleyMary Jeanne Kreek. (2015) A Window of Opportunity: Maximizing the Effectiveness of New HCV Regimens in the United States With the Expansion of the Affordable Care Act. American Journal of Public Health 105:3, pages 457-463.
Crossref
Crossref
Han-Zhu Qian, Valerie J Mitchell, Sally Bebawy, Holly Cassell, Gina Perez, Catherine C McGowan, Timothy R Sterling, Sten H Vermund, Richard D’Aquila & Todd Hulgan. (2014) Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report. BMC Infectious Diseases 14:1.
Crossref
Crossref
Nicholas W.S. Davies & Bruce J. Brew. 2014. HIV and Psychiatry. HIV and Psychiatry
107
156
.
David S. Metzger. 2014. Biomedical Advances in HIV Prevention. Biomedical Advances in HIV Prevention
161
177
.
David B. Hanna, Kate Buchacz, Kelly A. Gebo, Nancy A. Hessol, Michael A. Horberg, Lisa P. Jacobson, Gregory D. Kirk, Mari M. Kitahata, P. Todd Korthuis, Richard D. Moore, Sonia Napravnik, Pragna Patel, Michael J. Silverberg, Timothy R. Sterling, James H. Willig, Ann Collier, Hasina Samji, Jennifer E. Thorne, Keri N. Althoff, Jeffrey N. Martin, Benigno Rodriguez, Elizabeth A. Stuart & Stephen J. Gange. (2013) Association between U.S. State AIDS Drug Assistance Program (ADAP) Features and HIV Antiretroviral Therapy Initiation, 2001–2009. PLoS ONE 8:11, pages e78952.
Crossref
Crossref
Jessica F. MagidsonC.J. Seitz-BrownAlyson ListhausBriana LindbergKatelyn E. AndersonStacey B. Daughters. (2013) Distress Tolerance and Use of Antiretroviral Therapy Among HIV-Infected Individuals in Substance Abuse Treatment. AIDS Patient Care and STDs 27:9, pages 518-523.
Crossref
Crossref
David B. Hanna, Kate Buchacz, Kelly A. Gebo, Nancy A. Hessol, Michael A. Horberg, Lisa P. Jacobson, Gregory D. Kirk, Mari M. Kitahata, P. Todd Korthuis, Richard D. Moore, Sonia Napravnik, Pragna Patel, Michael J. Silverberg, Timothy R. Sterling, James H. Willig, Bryan Lau, Keri N. Althoff, Heidi M. Crane, Ann C. Collier, Hasina Samji, Jennifer E. Thorne, M. John Gill, Marina B. Klein, Jeffrey N. Martin, Benigno Rodriguez, Sean B. Rourke, Stephen J. Gange, A. Benson, Ronald J. Bosch, Ann C. Collier, Stephen Boswell, Chris Grasso, Ken Mayer, Robert S. Hogg, Richard Harrigan, Julio Montaner, Angela Cescon, John T. Brooks, Kate Buchacz, Kelly A. Gebo, Richard D. Moore, Benigno Rodriguez, Michael A. Horberg, Michael J. Silverberg, Jennifer E. Thorne, James J. Goedert, Lisa P. Jacobson, Marina B. Klein, Sean B. Rourke, Ann Burchell, Anita R. Rachlis, Robert F. Hunter-Mellado, Angel M. Mayor, M. John Gill, Steven G. Deeks, Jeffrey N. Martin, Michael S. Saag, Michael J. Mugavero, James Willig, Joseph J. Eron, Sonia Napravnik, Mari M. Kitahata, Heidi M. Crane, Amy C. Justice, Robert Dubrow, David Fiellin, Timothy R. Sterling, David Haas, Sally Bebawy, Megan Turner, Stephen J. Gange, Kathryn Anastos, Richard D. Moore, Michael S. Saag, Stephen J. Gange, Mari M. Kitahata, Rosemary G. McKaig, Amy C. Justice, Aimee M. Freeman, Richard D. Moore, Aimee M. Freeman, Carol Lent, Aaron Platt, Mari M. Kitahata, Stephen E. Van Rompaey, Heidi M. Crane, Eric Webster, Liz Morton, Brenda Simon, Stephen J. Gange, Alison G. Abraham, Bryan Lau, Keri N. Althoff, Jinbing Zhang, Jerry Jing, Elizabeth Golub, Shari Modur, David B. Hanna, Peter Rebeiro, Cherise Wong & Adell Mendes. (2013) Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001–2009. Clinical Infectious Diseases 56:8, pages 1174-1182.
Crossref
Crossref
Alex J. Mitchell, Oliver Lord & Darren Malone. (2018)
Differences in the prescribing of medication for physical disorders in individuals with
v.
without mental illness: meta-analysis
. British Journal of Psychiatry 201:6, pages 435-443.
Crossref
Crossref
Carla L. Storr, Lauren R. Pacek & Silvia S. Martins. (2012) Substance Use Disorders and Adolescent Psychopathology. Public Health Reviews 34:2.
Crossref
Crossref
M-J. Milloy, Thomas Kerr, Jane Buxton, Tim Rhodes, Andrea Krusi, Silvia Guillemi, Robert Hogg, Julio Montaner & Evan Wood. (2012) Social and Environmental Predictors of Plasma HIV RNA Rebound Among Injection Drug Users Treated With Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 59:4, pages 393-399.
Crossref
Crossref
Adam Gonzalez, Jennifer Barinas & Conall O’Cleirigh. (2011) Substance Use: Impact on Adherence and HIV Medical Treatment. Current HIV/AIDS Reports 8:4, pages 223-234.
Crossref
Crossref
Adam W Carrico, David R Bangsberg, Sheri D Weiser, Maggie Chartier, Samantha E Dilworth & Elise D Riley. (2011) Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons. AIDS 25:8, pages 1113-1118.
Crossref
Crossref
T. Tony Trinh, Brian T. Montague, Timothy P. Flanigan & Hoang My Gerard. (2011) HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City. AIDS Research and Treatment 2011, pages 1-7.
Crossref
Crossref
David S Metzger, George E Woody & Charles P O'Brien. (2010) Drug Treatment as HIV Prevention: A Research Update. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:Supplement 1, pages S32-S36.
Crossref
Crossref
David S. Metzger & Yan Zhang. (2010) Drug Treatment as HIV Prevention: Expanding Treatment Options. Current HIV/AIDS Reports 7:4, pages 220-225.
Crossref
Crossref
Rae Jean Proeschold-BellAmy HeineBrian Wells PenceKeith McAdamEvelyn Byrd Quinlivan. (2010) A Cross-Site, Comparative Effectiveness Study of an Integrated HIV and Substance Use Treatment Program. AIDS Patient Care and STDs 24:10, pages 651-658.
Crossref
Crossref
Nancy B PalmerJames R BasinskiKarina K Uldall. (2010) Psychiatric illness, access and adherence to HAART: a brief review of recent findings and implications for care. HIV Therapy 4:2, pages 215-230.
Crossref
Crossref